Disclaimer: The content is for educational purposes and not a substitute for medical advice.
What shapes Human Papillomavirus 16 (HPV16) as the biggest outlaw amongst the gang of 200 oddball types of Human Papillomavirus strains aka goons - isn’t a mystery. Those who look down upon genital warts caused by low-risk HPV eventually end up heaving a sigh of relief: “At least it’s not high-risk HPV!”
In plain sight, the carcinogenic notoriety of Human Papillomavirus 16 by and large continues to dominate conversations and is perhaps most importantly - feared.
In a bid to understand the Human Papillomavirus 16 from close quarters, See You In 2050 has dug into some hard cold facts about this “prime suspect” under question. And for good reason. Here goes!
The Stats behind Human Papillomavirus Genotype 16
You incidentally dashing into the shady world of Human Papillomavirus (HPV) is not rare - it's almost universal. Around 80%¹ of sexually active people have met HPV somewhere, sometime - via oral sex here, or anal sex there. It’s ridiculously common.
But what changes the plot is when you catch a High-risk Human Papillomavirus (High-risk HPV) strain - that is supposedly “Most Wanted” for a list of organ-related cancers. Anal Cancer. Throat Cancer. Penile Cancer. Vulvar Cancer. Vaginal Cancer. You name it! By contrast, the Low-risk HPV Virus - HPV 6 and HPV 11 may target you with the distressing genital and anal warts - but these conditions are not fatal and generally manageable.
HPV 16 is the mastermind.
It usually gives out no visible symptoms. No warts. No itching. No pain. And all of a sudden you have an ambush! The statistic that makes Human Papillomavirus Genotype 16 the most dangerous of the lot is that - it alone, along with HPV 18 cause 60-70% of all cervical cancers globally².
Plus, the Human Papillomavirus Genotype 16 is more likely to persist in your body over other HPV types.
Does Persistent High-risk HPV 16 Virus Ever Clear?
Understand this, nearly every dividing cell in your body has a control system that halts abnormal growth. This happens on a daily basis.
Think of it as your body's built-in quality control system, working around the clock to keep cancer at bay. Conclusively, most of us avoid cancer on a daily basis, without even acknowledging the cells that wage the war on our behalf.
When a persistent HPV Type 16 virus enters the body, it, unfortunately, hits at this very system. The E6 and E7 viral proteins of the high-risk HPV virus hijack your cellular machinery disabling the above-mentioned natural defense mechanisms - increasing your cancer risk and creating conditions that can eventually lead to cancer³.
Avoiding the theatrics, the cancer as such doesn’t happen in a day. It can take years, sometimes a decade. You wouldn’t have a clue! How does this happen?
Well, it begins with the virus finding an entry into your cervix, vagina, vulva, penis, anus, mouth and throat. For most people, it is said, high-risk HPV clears up in one to two years - more so in the younger population with stronger immunity defense.
But what if the virus appears positive, consecutively on the known high-risk human papillomavirus lab test? Persistent infection with high-risk HPV 16 carries the highest risk of progressing to cervical cancer and several other HPV-related cancers.
What if your high-risk HPV 16 test comes back negative? Have you cleared HPV for good? Well, a recent study says otherwise. Getting a high-risk HPV 16 negative report may mean your body has cleared the virus or the virus has gone into a hidden “Latent” phase suppressed by your strong immune response. High-risk HPV 16 virus in “Latent Phase” means the virus has become undetectable, the viral activity is suppressed or the virus may reactivate later. A negative HPV 16 test does not necessarily prove the virus has been completely eliminated⁵.
Scientists are still studying why latent HPV occasionally reactivates, particularly when immune surveillance weakens.
Likewise, a negative HPV test does not rule out every cause of abnormal cervical cells. This is why routine cervical screening remains important⁶.
On a Positive Note
HPV16 has earned its reputation. But reputation isn't destiny.
Most HPV infections never become cancer. Your immune system, HPV vaccination, and routine cervical screening stack the odds firmly in your favour.
A positive HPV16 test is not a cancer diagnosis either . It's simply a signal to pay attention - not panic.
The virus may write the opening chapter. What happens next is largely shaped by early detection, informed decisions, and timely follow-up.
Knowledge beats fear. Every single time.
References:
1) NCBI, The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States https://pmc.ncbi.nlm.nih.gov/articles/PMC6745688/
2) JNCI, The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice https://academic.oup.com/jnci/article-abstract/97/14/1072/2521312?redirectedFrom=fulltext
3) NCBI, Natural History of HPV Infection across the Lifespan: Role of Viral Latency https://pmc.ncbi.nlm.nih.gov/articles/PMC5691619/
4) Nature.com Human papillomavirus oncoproteins: pathways to transformation https://www.nature.com/articles/nrc2886
5) NCBI, Human Papillomavirus in Older Women: New Infection or Reactivation? https://pmc.ncbi.nlm.nih.gov/articles/PMC3532821/
6) National Cancer Institute, Cervical Cancer Screening https://www.cancer.gov/types/cervical/screening